Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium efficacy and adverse effects.

A J Gelenberg1

  • 1Special Studies Clinic, Arbour and Massachusetts General, Boston.

The Journal of Clinical Psychiatry
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Counterpoint : psychopharmacology supervision.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction.

International journal of impotence research·2006
Same author

Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression.

Acta psychiatrica Scandinavica·2006
Same author

Bipolar disorder in women: reproductive events and treatment considerations.

Acta psychiatrica Scandinavica·2005
Same author

Citalopram as adjunctive therapy in bipolar depression.

The Journal of clinical psychiatry·2002
Same author

Can lithium help to prevent suicide?

Acta psychiatrica Scandinavica·2001
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Lithium is a key treatment for bipolar disorder, helping prevent relapse and acute mania. Once-daily dosing may reduce side effects and risks like neurotoxicity and fetal abnormalities.

Area of Science:

  • Psychiatry and Pharmacology

Background:

  • Lithium is a primary maintenance treatment for bipolar disorders, effective for acute mania.
  • Often requires co-administration with neuroleptics for optimal efficacy.

Purpose of the Study:

  • To summarize the therapeutic uses and potential risks of lithium treatment.
  • To highlight strategies for optimizing lithium therapy and patient safety.

Main Methods:

  • Review of existing literature on lithium's efficacy and safety in bipolar disorder management.
  • Analysis of side effect profiles and risk factors associated with lithium use.

Main Results:

  • Once-daily lithium therapy may mitigate side effects and long-term renal damage.
  • Combined use of lithium and neuroleptics can lead to neurotoxicity in sensitive individuals.

Related Experiment Videos

  • Lithium use in the first trimester of pregnancy poses risks for fetal cardiovascular abnormalities.

    • Conclusions:

    • Lithium remains crucial for bipolar disorder management, with potential for improved safety through specific dosing strategies.
    • Careful patient selection and monitoring are essential to minimize risks, particularly neurotoxicity and teratogenicity.